{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T05:00:42Z","timestamp":1793854842112,"version":"4.6.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Colorectal cancer (CRC) frequently metastasizes to the liver and lungs, leading to poor prognosis. Advances in chemotherapy, minimally invasive surgery, and perioperative care have expanded adjuvant chemotherapy (AC) regimens and eligibility for AC. However, the impact of AC after curative resection of distant metastases on recurrence and prognosis remains uncertain. This study evaluated the role of AC in CRC liver and lung metastases, focusing on cases with curative resection based on the latest studies published in the past five years.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This systematic review followed PRISMA guidelines. Literature searches of Medline and Cochrane Library (2019\u20132023) identified studies on AC or observation after curative resection of CRC metastases, reporting outcomes such as overall survival (OS) and disease-free survival (DFS). Data analysis was performed using Review Manager and R software, with results expressed as hazard ratios (HR) and 95% confidence intervals (CI).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Seven studies met the eligibility criteria, including one randomized controlled trial and six retrospective studies, encompassing 1580 patients who underwent curative resection (R0) for CRC metastases. This meta-analysis showed a positive trend in OS for the AC group compared to that for the surgery-alone group (HR 0.86, 95% CI: 0.73\u20131.01; <jats:italic>p<\/jats:italic>\u2009=\u20090.06), but the difference was insignificant. AC significantly improved DFS (HR 0.81, 95% CI: 0.66\u20130.99; <jats:italic>p<\/jats:italic>\u2009=\u20090.04). Subgroup analysis indicated that AC significantly improved DFS and tended to improve OS for liver metastasis. In contrast, AC did not improve OS in cases of lung metastasis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This meta-analysis suggests that AC demonstrated significant positive effects on DFS. Moreover, AC could contribute to improvements in OS. These findings, supported by the latest research, reinforce the recommendation of AC as a valuable strategy for improving both recurrence and survival outcomes in patients with curatively resected distant CRC metastases.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12957-025-03714-4","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T06:40:32Z","timestamp":1739860832000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Updated insights into the impact of adjuvant chemotherapy on recurrence and survival after curative resection of liver or lung metastases in colorectal cancer: a rapid review and meta-analysis"],"prefix":"10.1186","volume":"23","author":[{"given":"Kyota","family":"Tatsuta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayu","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadahiro","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisuke","family":"Booka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyotaka","family":"Kurachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroya","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,18]]},"reference":[{"key":"3714_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17\u201348.","journal-title":"CA Cancer J Clin"},{"key":"3714_CR2","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.canep.2017.04.003","volume":"48","author":"JR Robinson","year":"2017","unstructured":"Robinson JR, Newcomb PA, Hardikar S, Cohen SA, Phipps AI. Stage IV colorectal cancer primary site and patterns of distant metastasis. Cancer Epidemiol. 2017;48:92\u20135.","journal-title":"Cancer Epidemiol"},{"key":"3714_CR3","first-page":"29765","volume":"6","author":"M Riihim\u00e4ki","year":"2016","unstructured":"Riihim\u00e4ki M, Hemminki A, Sundquist J, Hemminki K. Patterns of metastasis in colon and rectal cancer. Sci re. 2016;6:29765.","journal-title":"Sci re"},{"key":"3714_CR4","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/ags3.12472","volume":"5","author":"H Ogawa","year":"2021","unstructured":"Ogawa H, Yajima T, Sohda M, Shirabe K, Saeki H. Role of surgical resection and its alternative local therapy for pulmonary metastasis of colorectal cancer. Ann Gastroenterol Surg. 2021;5:747\u201353.","journal-title":"Ann Gastroenterol Surg"},{"key":"3714_CR5","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/ags3.12227","volume":"3","author":"R Adam","year":"2019","unstructured":"Adam R, Kitano Y. Multidisciplinary approach of liver metastases from colorectal cancer. Ann Gastroenterol Surg. 2019;3:50\u20136.","journal-title":"Ann Gastroenterol Surg"},{"key":"3714_CR6","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2165\/00003495-198631040-00004","volume":"31","author":"SK Carter","year":"1986","unstructured":"Carter SK. Adjuvant chemotherapy of Cancer. Drugs. 1986;31:337\u201367.","journal-title":"Drugs"},{"key":"3714_CR7","doi-asserted-by":"publisher","first-page":"4976","DOI":"10.1200\/JCO.2006.06.8353","volume":"24","author":"G Portier","year":"2006","unstructured":"Portier G, Elias D, Bouche O, Rougier P, Bosset J-F, Saric J, et al. Multicenter Randomized Trial of Adjuvant Fluorouracil and Folinic Acid compared with surgery alone after resection of Colorectal Liver metastases: FFCD ACHBTH AURC 9002 Trial. J Clin Oncol. 2006;24:4976\u201382.","journal-title":"J Clin Oncol"},{"key":"3714_CR8","doi-asserted-by":"publisher","first-page":"e0162400","DOI":"10.1371\/journal.pone.0162400","volume":"11","author":"K Hasegawa","year":"2016","unstructured":"Hasegawa K, Saiura A, Takayama T, Miyagawa S, Yamamoto J, Ijichi M, et al. Adjuvant oral uracil-tegafur with leucovorin for colorectal cancer liver metastases: a randomized controlled trial. PLoS ONE. 2016;11:e0162400.","journal-title":"PLoS ONE"},{"key":"3714_CR9","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1007\/s00384-019-03362-7","volume":"34","author":"C Zhang","year":"2019","unstructured":"Zhang C, Tan Y, Xu H. Does adjuvant chemotherapy improve the prognosis of patients after resection of pulmonary metastasis from colorectal cancer? A systematic review and meta-analysis. Int J Colorectal Dis. 2019;34:1661\u201371.","journal-title":"Int J Colorectal Dis"},{"key":"3714_CR10","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.athoracsur.2018.02.065","volume":"106","author":"C Menna","year":"2018","unstructured":"Menna C, Berardi G, Tierno SM, Andreetti C, Maurizi G, Ciccone AM, et al. Do Repeated Operations for Recurrent Colorectal Lung Metastases Result in Improved Survival? Ann Thorac Sur. 2018;106:421\u20137.","journal-title":"Ann Thorac Sur"},{"key":"3714_CR11","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.21037\/jtd.2016.05.98","volume":"8","author":"F Guerrera","year":"2016","unstructured":"Guerrera F, Mossetti C, Ceccarelli M, Bruna MC, Bora G, Olivetti S, et al. Surgery of colorectal cancer lung metastases: analysis of survival, recurrence and re-surgery. J Thorac Dis. 2016;8:1764\u201371.","journal-title":"J Thorac Dis"},{"key":"3714_CR12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/ags3.12307","volume":"4","author":"T Akagi","year":"2020","unstructured":"Akagi T, Inomata M, Essential. Updates 2018\/2019: essential advances in surgical and adjuvant therapies for colorectal cancer. Ann Gastroenterol Surg. 2020;4:39\u201346.","journal-title":"Ann Gastroenterol Surg"},{"key":"3714_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/ags3.12601","volume":"7","author":"K Mima","year":"2023","unstructured":"Mima K, Nakagawa S, Miyata T, Yamashita Y, Baba H. Frailty and surgical outcomes in gastrointestinal cancer: integration of geriatric assessment and prehabilitation into surgical practice for vulnerable patients. Ann Gastroenterol Surg. 2023;7:27\u201341.","journal-title":"Ann Gastroenterol Surg"},{"key":"3714_CR14","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/ags3.12792","volume":"8","author":"N Ikoma","year":"2024","unstructured":"Ikoma N. What defines the value of robotic surgery for patients with gastrointestinal cancers? Perspectives from a U.S. Cancer Center. Ann Gastroenterol Surg. 2024;8:566\u201379.","journal-title":"Ann Gastroenterol Surg"},{"key":"3714_CR15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s11748-012-0185-1","volume":"61","author":"H Nakamura","year":"2013","unstructured":"Nakamura H, Taniguchi Y. Robot-assisted thoracoscopic surgery: current status and prospects. Gen Thorac Cardiovasc Surg. 2013;61:127\u201332.","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"3714_CR16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/ags3.12322","volume":"4","author":"N Kokudo","year":"2020","unstructured":"Kokudo N, Takemura N, Ito K, Mihara F. The history of liver surgery: achievements over the past 50 years. Ann Gastroenterol Surg. 2020;4:109\u201317.","journal-title":"Ann Gastroenterol Surg"},{"key":"3714_CR17","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"3714_CR18","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.","journal-title":"BMJ"},{"key":"3714_CR19","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.","journal-title":"BMJ"},{"key":"3714_CR20","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","volume":"64","author":"H Balshem","year":"2011","unstructured":"Balshem H, Helfand M, Sch\u00fcnemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64:401\u20136.","journal-title":"J Clin Epidemiol"},{"key":"3714_CR21","doi-asserted-by":"crossref","unstructured":"Kanemitsu Y, Shimizu Y, Mizusawa; Junki, Inaba Y, Hamaguchi T, Dai Shida,;, et al. Hepatectomy followed by mFOLFOX6 Versus Hepatectomy alone for liver-only metastatic colorectal Cancer (JCOG0603): a phase II or III randomized controlled trial. J Clin Oncol. 2021;39:3789\u201399.","DOI":"10.1200\/JCO.21.01032"},{"key":"3714_CR22","doi-asserted-by":"crossref","unstructured":"Kelm M, Schollbach J, Anger F, Wiegering A, Klein I, Germer CT, et al. Prognostic impact of additive chemotherapy after curative resection of metachronous colorectal liver metastasis: a single-centre retrospective study. BMC Cancer. 2021;21:490.","DOI":"10.1186\/s12885-021-07941-2"},{"key":"3714_CR23","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1007\/s11605-019-04250-9","volume":"24","author":"S Kobayashi","year":"2020","unstructured":"Kobayashi S, Beppu T, Honda G, Yamamoto M, Takahashi K, Endo I, et al. Survival Benefit of and indications for Adjuvant Chemotherapy for Resected Colorectal Liver Metastases\u2014a Japanese Nationwide Survey. J Gastrointest Surg. 2020;24:1244\u201360.","journal-title":"J Gastrointest Surg"},{"key":"3714_CR24","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ejca.2018.10.003","volume":"106","author":"M Imanishi","year":"2019","unstructured":"Imanishi M, Yamamoto Y, Hamano Y, Yamada T, Moriwaki T, Gosho M, et al. Efficacy of adjuvant chemotherapy after resection of pulmonary metastasis from colorectal cancer: a propensity score\u2013matched analysis. Eur J Cancer. 2019;106:69\u201377.","journal-title":"Eur J Cancer"},{"key":"3714_CR25","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1002\/jso.27188","volume":"127","author":"P Hansdotter","year":"2023","unstructured":"Hansdotter P, Scherman P, Nikberg M, Petersen SH, Holmberg E, Rizell M, et al. Treatment and survival of patients with metachronous colorectal lung metastases. J Surg Oncol. 2023;127:806\u201314.","journal-title":"J Surg Oncol"},{"key":"3714_CR26","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.surg.2021.04.012","volume":"170","author":"T Kokudo","year":"2021","unstructured":"Kokudo T, Saiura A, Takayama T, Miyagawa S, Yamamoto J, Ijichi M, et al. Adjuvant chemotherapy can prolong recurrence-free survival but did not influence the type of recurrence or subsequent treatment in patients with colorectal liver metastases. Surgery. 2021;170:1151\u20134.","journal-title":"Surgery"},{"key":"3714_CR27","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.hpb.2020.08.018","volume":"23","author":"T Boerner","year":"2021","unstructured":"Boerner T, Zambirinis C, Gagni\u00e8re J, Chou JF, Gonen M, Kemeny NE, et al. Early liver metastases after failure of adjuvant chemotherapy for stage III colorectal cancer: is there a role for additional adjuvant therapy? HPB. 2021;23:601\u20138.","journal-title":"HPB"},{"key":"3714_CR28","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3748\/wjg.v22.i2.519","volume":"22","author":"G Brandi","year":"2016","unstructured":"Brandi G. Adjuvant chemotherapy for resected colorectal cancer metastases: literature review and meta-analysis. World J Gastroenterol. 2016;22:519\u201333.","journal-title":"World J Gastroenterol"},{"key":"3714_CR29","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0140-6736(95)90696-7","volume":"345","author":"S Marsoni","year":"1995","unstructured":"Marsoni S, Negri M. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer International Multicentre pooled analysis of Colon cancer trials (IMPACT) investigators. Lancet. 1995;345:939\u201344.","journal-title":"Lancet"},{"key":"3714_CR30","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1200\/JCO.2008.20.6771","volume":"27","author":"T Andr\u00e9","year":"2009","unstructured":"Andr\u00e9 T, Boni C, Navarro M, Tabernero J, Hickish T, Topham C, et al. Improved overall survival with oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment in Stage II or III Colon cancer in the MOSAIC Trial. J Clin Oncol. 2009;27:3109\u201316.","journal-title":"J Clin Oncol"},{"key":"3714_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10147-019-01485-z","volume":"25","author":"Y Hashiguchi","year":"2020","unstructured":"Hashiguchi Y, Muro K, Saito Y, Ito Y, Ajioka Y, Hamaguchi T, et al. Japanese Society for Cancer of the Colon and rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol. 2020;25:1\u201342.","journal-title":"Int J Clin Oncol"},{"key":"3714_CR32","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","volume":"34","author":"A Cervantes","year":"2023","unstructured":"Cervantes A, Adam R, Rosell\u00f3 S, Arnold D, Normanno N, Ta\u00efeb J, et al. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023;34:10\u201332.","journal-title":"Ann Oncol"},{"key":"3714_CR33","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/S1470-2045(13)70447-9","volume":"14","author":"B Nordlinger","year":"2013","unstructured":"Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, et al. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol. 2013;14:1208\u201315.","journal-title":"Lancet Oncol"},{"key":"3714_CR34","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/S0140-6736(08)60455-9","volume":"371","author":"B Nordlinger","year":"2008","unstructured":"Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet. 2008;371:1007\u201316.","journal-title":"Lancet"},{"key":"3714_CR35","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/oncolo\/oyac209","volume":"28","author":"Z Hao","year":"2023","unstructured":"Hao Z, Parasramka S, Chen Q, Jacob A, Huang B, Mullett T, et al. Neoadjuvant Versus Adjuvant Chemotherapy for Resectable metastatic Colon cancer in non-academic and academic programs. Oncologist. 2023;28:48\u201358.","journal-title":"Oncologist"},{"key":"3714_CR36","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.3390\/jcm12062401","volume":"12","author":"E Georgilis","year":"2023","unstructured":"Georgilis E, Gavriatopoulou M, Tsilimigras DI, Malandrakis P, Theodosopoulos T, Ntanasis-Stathopoulos I. Optimizing adjuvant therapy after surgery for Colorectal Cancer Liver metastases: a systematic review. J Clin Med. 2023;12:2401.","journal-title":"J Clin Med"},{"key":"3714_CR37","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1016\/j.clcc.2019.12.001","volume":"19","author":"P Cavallaro","year":"2020","unstructured":"Cavallaro P, Bordeianou L, Stafford C, Clark J, Berger D, Cusack J, et al. Impact of single-organ metastasis to the liver or lung and genetic mutation status on prognosis in Stage IV Colorectal Cancer. Clin Colorectal Cancer. 2020;19:e8\u201317.","journal-title":"Clin Colorectal Cancer"},{"key":"3714_CR38","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1080\/0284186X.2018.1487581","volume":"57","author":"T Prasanna","year":"2018","unstructured":"Prasanna T, Karapetis CS, Roder D, Tie J, Padbury R, Price T, et al. The survival outcome of patients with metastatic colorectal cancer based on the site of metastases and the impact of molecular markers and site of primary cancer on metastatic pattern. Acta Oncol. 2018;57:1438\u201344.","journal-title":"Acta Oncol"},{"key":"3714_CR39","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1002\/cncr.28729","volume":"120","author":"R Yaeger","year":"2014","unstructured":"Yaeger R, Cercek A, Chou JF, Sylvester BE, Kemeny NE, Hechtman JF, et al. BRAF mutation predicts for poor outcomes after metastasectomy in patients with metastatic colorectal cancer. Cancer. 2014;120:2316\u201324.","journal-title":"Cancer"},{"key":"3714_CR40","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.clcc.2012.06.004","volume":"11","author":"MA Khattak","year":"2012","unstructured":"Khattak MA, Martin HL, Beeke C, Price T, Carruthers S, Kim S, et al. Survival differences in patients with metastatic colorectal Cancer and with single site metastatic disease at initial presentation: results from South Australian Clinical Registry for Advanced Colorectal Cancer. Clin Colorectal Cancer. 2012;11:247\u201354.","journal-title":"Clin Colorectal Cancer"},{"key":"3714_CR41","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1245\/s10434-011-2179-0","volume":"19","author":"NB Jones","year":"2012","unstructured":"Jones NB, McNally ME, Malhotra L, Abdel-Misih S, Martin EW, Bloomston M, et al. Repeat hepatectomy for metastatic colorectal Cancer is safe but marginally effective. Ann Surg Oncol. 2012;19:2224\u20139.","journal-title":"Ann Surg Oncol"},{"key":"3714_CR42","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12957-019-1575-y","volume":"17","author":"H Matsuoka","year":"2019","unstructured":"Matsuoka H, Morise Z, Tanaka C, Hayashi T, Ikeda Y, Maeda K, et al. Repeat hepatectomy with systemic chemotherapy might improve survival of recurrent liver metastasis from colorectal cancer\u2014a retrospective observational study. World J Surg Oncol. 2019;17:33.","journal-title":"World J Surg Oncol"},{"key":"3714_CR43","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1002\/jso.27056","volume":"126","author":"CD Valenzuela","year":"2022","unstructured":"Valenzuela CD, Moaven O, Gawdi R, Stauffer JA, Del Piccolo NR, Cheung TT, et al. Outcomes after repeat hepatectomy for colorectal liver metastases from the colorectal liver operative metastasis international collaborative (COLOMIC). J Surg Oncol. 2022;126:1242\u201352.","journal-title":"J Surg Oncol"},{"key":"3714_CR44","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00423-016-1547-4","volume":"402","author":"S Sponholz","year":"2017","unstructured":"Sponholz S, Schirren M, Baldes N, Oguzhan S, Schirren J. Repeat resection for recurrent pulmonary metastasis of colorectal cancer. Langenbecks Arch Surg. 2017;402:77\u201385.","journal-title":"Langenbecks Arch Surg"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03714-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-03714-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03714-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T06:40:36Z","timestamp":1739860836000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-025-03714-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,18]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3714"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-03714-4","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,18]]},"assertion":[{"value":"25 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"56"}}